VanEck ETF Trust - VanEck Pharmaceutical ETF
US ˙ NasdaqGM ˙ US92189F6925

SecurityPPH / VanEck ETF Trust - VanEck Pharmaceutical ETF
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership14,177 shares
Latest Disclosed Value $ 1,473,139
Advisor Group Holdings, Inc. reports 11.52% decrease in ownership of PPH / VanEck ETF Trust - VanEck Pharmaceutical ETF

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 14,177 shares of VanEck ETF Trust - VanEck Pharmaceutical ETF (US:PPH) valued at $1,472,707 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 16,023 shares of VanEck ETF Trust - VanEck Pharmaceutical ETF. This represents a change in shares of -11.52% during the quarter. The current value of the position is $1,499,218 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 14,177 -1,846 -11.52 1,473 -10.89 0.0013
2026-02-17 2025-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 16,023 -6,522 -28.93 1,654 -17.92 0.0024
2025-11-14 2025-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 22,545 420 1.90 2,014 3.49 0.0028
2025-09-04 2025-06-30 13F/A-1 ANECK ETF TRUST PHARMACEUTCL ETF 92189F692 22,125 9,992 82.35 1,946 75.95 0.0035
2025-08-13 2025-06-30 13F ANECK ETF TRUST PHARMACEUTCL ETF 92189F692 19,781 7,648 1,724 0.0020
2025-05-12 2025-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 12,133 -42,770 -77.90 1,106 -45.25 0.0025
2025-06-06 2024-12-31 13F/A-1 VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 54,903 32,164 141.45 2,021 -6.52 0.0045
2025-02-07 2024-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 54,580 31,841 2,074 0.0053
2024-11-13 2024-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 22,739 -1,979 -8.01 2,161 -4.42 0.0049
2024-08-13 2024-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 24,718 -8,530 -25.66 2,261 -25.01 0.0053
2024-05-10 2024-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 33,248 12,130 57.44 3,016 75.49 0.0067
2024-02-12 2023-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 21,118 7,559 55.75 1,718 58.78 0.0030
2023-11-13 2023-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 13,559 3,470 34.39 1,083 36.27 0.0016
2023-08-21 2023-06-30 13F/A-1 VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 10,089 3,690 57.67 795 60.08 0.0014
2023-08-10 2023-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 10,089 3,690 795 0.0002
2023-05-12 2023-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 6,399 -1,731 -21.29 497 -21.39 0.0009
2023-02-10 2022-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 8,130 -21 -0.26 632 15.15 0.0013
2022-11-14 2022-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 8,151 5,341 190.07 548 153.70 0.0013
2022-08-10 2022-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 2,810 440 18.57 216 14.89 0.0005
2022-05-04 2022-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 2,370 -18,976 -88.90 188 -88.55 0.0004
2022-02-03 2021-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 21,346 12,578 143.45 1,642 157.37 0.0031
2021-11-05 2021-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 8,768 -25,309 -74.27 638 -74.37 0.0013
2021-08-02 2021-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 34,077 31,879 1,450.36 2,489 1,548.34 0.0054
2021-05-13 2021-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 2,198 7 0.32 151 3.42 0.0004
2021-02-10 2020-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 2,191 -100 -4.36 146 2.82 0.0004
2020-11-12 2020-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 2,291 665 40.90 142 40.59 0.0004
2020-08-14 2020-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 1,626 -208 -11.34 101 1.00 0.0003
2020-05-18 2020-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 1,834 1,834 100 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.